Several studies have shown that in patients with early symptomatic AD, the level of VILIP-1 in cerebrospinal fluid is closely related to whole and regional brain atrophy and is associated with amyloid load in normal individuals in cognition (Tarawneh et al., 2012). The gene discussed is VSNL1; the disease is Alzheimer disease.